EMF Research Data

in

Phase II — Single-blind Challenge of 100 Patients

No. of Patients

No. of Active Challenges

No. of Blank Challenges

Positive Reactions to Active Challenges

Positive Reactions to Blanks

50 1050 250 750 150 25 525 125 0 0 25 525 125 325 0

 


Table 2

Phase III — 25 Patients Previously Positive

Rechallenged and 25 Controls Tested Double-Blind

No. of Persons

No. of Active Challenges

No. of Blank Challenges

Positive Reactions to Challenges

Positive Reactions to Blanks

16 patients

(out of 25 reacting positively)

336 80 179 6

25 controls

(none of them reacting positively)

525 125 0 0

 


Table 3

Percentage of 16 Patients with Positive Reaction to Different Frequencies

Frequency (Hz) Patients with Positive Reaction (%) Frequency (Hz)

Patients with Positive Reaction (%)

0.1 31 1K 56
0.5 44 5K 38
1.0 75 10K 69
2.5 75 20K 56
5.0 69 35K 31
10.0 69 50K 50
20.0 69 75K 50
40.0 50 100K 38
50.0 50 1M 50
60.0 63 5M 31
100.0 56


Table 4

Comparison of Symptoms and Signs Induced by Frequencies

Hz # Patients w/pos reaction Neuro-
logical		 Musculo-
skeletal		 Cardio-
vascular		 Respiratory Gastro-
intestinal		 Eyes Skin
# of Pts % # of Pts % # of Pts % # of Pts % # of Pts % # of Pts % # of Pts %

0.1

5 3 60 0 0 0 0 0 0 1 20 0 0 0 0

0.5

7 4 57 0 0 0 0 0 0 0 0 0 0 0 0

1

12 4 33 3 25 0 0 1 8 1 8 0 0 0 0

2.5

12 5 42 2 17 0 0 1 8 1 8 0 0 0 0

5

11 5 46 0 0 1 9 2 18 1 9 0 0 0 0

10

11 7 64 1 9 0 0 2 18 0 0 0 0 0 0

20

11 4 36 0 0 1 9 1 9 1 9 0 0 0 0

40

8 4 50 0 0 0 0 2 25 0 0 0 0 1 13

50

8 5 63 0 0 2 25 1 13 0 0 0 0 0 0

60

10 5 50 0 0 1 10 3 30 0 0 0 0 0 0

100

9 4 44 0 0 1 11 2 22 1 11 0 0 0 0

1K

9 6 67 0 0 1 11 0 0 0 0 1 11 0 0

5K

6 2 33 1 17 0 0 1 17 0 0 0 0 0 0

10K

11 4 36 1 9 0 0 0 0 0 0 0 0 0 0

20K

9 5 56 0 0 2 22 0 0 0 0 0 0 1 11

35K

5 2 40 0 0 0 0 1 20 0 0 0 0 1 20

50K

8 2 25 0 0 1 13 2 25 0 0 0 0 1 13

75K

8 1 13 0 0 1 13 3 38 0 0 1 13 0 0

100K

6 2 33 2 33 0 0 2 33 0 0 0 0 0 0

1M

8 4 50 1 13 0 0 0 0 0 0 0 0 0 0

5M

5 2 40 1 20 0 0 0 0 0 0 0 0 0 0

Table 5

Phase IV—Sixteen Patients Rechallenged to One Active Frequency on Two Separate Episoded and in Addition to Five Blank Challenges on Each Episode—Double-blind

First Episode of Challenge



No. of

Patients

Total No. of Frequencies Total No. of Blanks

No. of Patients Reacting to Active Challenge

No. of Patients Reacting to Blanks

16 16 80 16 0





Second Episode of Challenge



No. 4 of Patients

Total No. of Frequencies Total No. of Blanks

No. of Patients Reacting to Active Challenge

No. of Patients Reacting to Blanks

16 16 80 16 0


Table 6

Parameters of 25 Normal Controls’ Pupillary Light Reflex—Iriscorder—EHC-Dallas

(Right and Left Eyes Combined)

Parameter


x ± SD


% Variation

Al

5.70 = 3.58 10.0

Cr

0.46 = 0.048 10.4

T2

190.74 = 18.36 9.6

VC

49.67 = 5.86 11.8

AC

503.20 = 75.80 15.1

T5

1520.04 = 286.86 18.7

VD

13.65 = 2.44 17.9

‹ EMF Referencesup